Digital Therapeutics Market 2025 by Application, End User and Key Players: Proteus Digital Health, Omada Health, Inc., WellDoc Inc., 2Morrow, Inc., Livongo Health, Propeller Health, Twinehealth

Industry Trend Analysis
The global digital therapeutics market is estimated to be around 9 billion by 2025. The market is expected to witness high growth during forecast period due to increase in demand for digitalization of healthcare and effective management of acute and chronic diseases. Besides rise in incidences of chronic diseases, technological up gradation, demand for preventive measures for management of diseases and rising demand for e-health will further drive the market growth. Increasing use of smartphones and growing number of internet users globally will significantly contribute to the growth of the market. Another vital factor responsible for the growth of digital therapeutics market is cost effectiveness of digital therapeutics as compared to traditional methods as it allows remote consultation to patients. Despite large investment in this segment, data privacy issues, lack of awareness about digital health programs and refusal from healthcare providers as well as patients will hamper the growth of the market.

Application Outlook and Trend Analysis
Diabetes segment is expected to witness highest growth over the forecast period, due to increase in prevalence of diabetes worldwide. According to the International Diabetes Federation (IDF), around 415 million people across globe were affected by diabetes as of 2015 and this number is expected to reach 642 million by 2040. Such a high prevalence of diabetes will primarily drive growth of the market. Preventive market segment is expected to witness fastest growth during forecast period. This can be attributed to factors such as increasing demand for pre-screening techniques for various chronic diseases and rise in demand for cost saving preventive healthcare programs.

Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/ICT/QBI-CMR-ICT-55022

Regional Outlook and Trend Analysis
North America accounted for the largest share of the global digital therapeutics market in 2016. This can be attributed to number of factors such as rise in elderly population requiring better healthcare facilities, presence of large number of digital therapy providers in the region, high rate of adoption of advanced medical devices and rise in demand for patient-centric healthcare procedures. Europe accounted for the second largest share of the global market in 2016 due to increase demand for digitalization of healthcare.

Asia-Pacific is expected to grow at fastest CAGR during forecast period owing to a number of factors such as increase in elderly population, changing healthcare infrastructure and increase in demand for cost saving screening and treatment techniques.

Competitive Insights
Product development facilitated through technological innovation is the major strategy adopted by the key players operating in the global digital therapeutics market. For instance, in January 2017, WellDoc, Inc. obtained FDA clearance for non-prescription version of their BlueStar digital therapeutic for patients suffering from type 2 diabetes.

Some of the major players operating in the global market are Proteus Digital Health, Omada Health, Inc., WellDoc Inc., 2Morrow, Inc., Livongo Health, Propeller Health, Twinehealth, Canary Health, Inc. Mango Health, Inc. and Noom, Inc.

Market opportunities
The digital therapeutics market will be driven by technologically advanced products over the coming years as demand for patient centric healthcare is on the rise globally. Digital therapeutics facilitates the intersection of science, design and technology to create market ready solutions that provide customized healthcare programs to the patients. Such developments will fuel the growth of this market over the forecast period.

Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/ICT/QBI-CMR-ICT-55022

Digital Therapeutics Market Segmentation:
By Application:
Preventive
Prediabetes
Obesity

Treatment/care
o Diabetes
o Medication Adherence
o Central Nervous System Disease
o Respiratory Diseases
o Musculoskeletal Diseases
o Smoking Cessation
o Cardiovascular Diseases
o Other Applications

By End User:
Patients
Employees
Payers
Providers
Others

Buy This Report@ https://www.qurateresearch.com/report/buy/ICT/QBI-CMR-ICT-55022/

By Region:
• North America
o U.S
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Rest of Asia-Pacific
• Rest of the World
o Brazil
o South Africa
o Saudi Arabia
o Turkey
o United Arab Emirates
o Others

Some of the key questions answered by the report are:
• What was the market size in 2016 and forecast from 2017 to 2025?
• What will be the industry market growth from 2017 to 2025?
• What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
• What are the major segments leading the market growth and why?
• Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Enquiry for Customization@ https://www.qurateresearch.com/report/customize/ICT/QBI-CMR-ICT-55022

About Us:
Qurate Business Intelligence delivers unique market research solutions to its customers and help them to get equipped with refined information and market insights derived from reports. We are committed to providing best business services and easy processes to get the same. Qurate Business Intelligence considers themselves as strategic partners of their customers and always shows the keen level of interest to deliver quality.

Runwal Platinum,
Ramnagar Colony, Bavdhan,
Pune, Maharashtra, India-411021
https://www.qurateresearch.com/
IN +919881074592
info@qurateresearch.com

This release was published on openPR.